Effectiveness of rehabilitation interventions in adults with multi-organ dysfunction syndrome: A rapid review.
multiple organ failure
rapid review
rehabilitation
Journal
Journal of rehabilitation medicine
ISSN: 1651-2081
Titre abrégé: J Rehabil Med
Pays: Sweden
ID NLM: 101088169
Informations de publication
Date de publication:
07 08 2021
07 08 2021
Historique:
pubmed:
27
5
2021
medline:
1
9
2021
entrez:
26
5
2021
Statut:
epublish
Résumé
Multiple organ dysfunction syndrome, defined as altered organ function in critically ill patients, is a possible consequence of COVID-19. Investigating the current evidence is therefore crucial in this pandemic, as early rehabilitation could be effective for the functioning of patients with multiple organ failure. This rapid review assesses the effectiveness of rehabilitation interventions in adults with multiple organ dysfunction syndrome. A rapid review was conducted including only randomised control trials, published until 30 November 2020. All databases were investigated and the results synthesized narratively, evaluating the risk of bias and quality of evidence in all included studies. A total of 404 records were identified through database searches. After removal of duplicates 346 articles remained. After screening, 3 studies (90 participants) met the inclusion criteria. All studies reported positive effects of neuromuscular electrical stimulation on muscle mass preservation compared with no treatment or standard physio-therapy. The lack of evidence on the effectiveness of rehabilitation interventions does not allow any firm conclusion to be drawn. Neuromuscular electrical stimulation might be a possible rehabilitation intervention to prevent muscle volume loss and improve function in patients with multiple organ dysfunction syndrome. However, further studies are needed to support these preliminary findings.
Sections du résumé
BACKGROUND
Multiple organ dysfunction syndrome, defined as altered organ function in critically ill patients, is a possible consequence of COVID-19. Investigating the current evidence is therefore crucial in this pandemic, as early rehabilitation could be effective for the functioning of patients with multiple organ failure. This rapid review assesses the effectiveness of rehabilitation interventions in adults with multiple organ dysfunction syndrome.
METHODS
A rapid review was conducted including only randomised control trials, published until 30 November 2020. All databases were investigated and the results synthesized narratively, evaluating the risk of bias and quality of evidence in all included studies.
RESULTS
A total of 404 records were identified through database searches. After removal of duplicates 346 articles remained. After screening, 3 studies (90 participants) met the inclusion criteria. All studies reported positive effects of neuromuscular electrical stimulation on muscle mass preservation compared with no treatment or standard physio-therapy.
CONCLUSION
The lack of evidence on the effectiveness of rehabilitation interventions does not allow any firm conclusion to be drawn. Neuromuscular electrical stimulation might be a possible rehabilitation intervention to prevent muscle volume loss and improve function in patients with multiple organ dysfunction syndrome. However, further studies are needed to support these preliminary findings.
Identifiants
pubmed: 34037239
doi: 10.2340/16501977-2846
pmc: PMC8638732
doi:
Types de publication
Journal Article
Review
Langues
eng
Sous-ensembles de citation
IM
Pagination
jrm00221Références
Nat Rev Dis Primers. 2016 Jun 30;2:16045
pubmed: 28117397
Ann Surg. 1998 Aug;228(2):146-58
pubmed: 9712558
PLoS Med. 2009 Jul 21;6(7):e1000097
pubmed: 19621072
Dis Mon. 2009 Aug;55(8):476-526
pubmed: 19595297
Crit Care Med. 2009 May;37(5):1649-54
pubmed: 19325482
J Crit Care. 2012 Jun;27(3):319.e1-8
pubmed: 21715139
J Clin Epidemiol. 2020 Oct;126:177-183
pubmed: 32615209
Crit Care Med. 2009 Sep;37(9):2499-505
pubmed: 19623052
Crit Care. 2009;13(5):R161
pubmed: 19814793
Intensive Care Med. 2003 Sep;29(9):1505-14
pubmed: 12879242
BMJ Evid Based Med. 2018 Feb;23(1):21-22
pubmed: 29367321
Crit Care Med. 2018 Sep;46(9):e825-e873
pubmed: 30113379
Arch Phys Med Rehabil. 2019 Aug;100(8):1492-1498
pubmed: 30831091
Am J Phys Med Rehabil. 2020 Mar;99(3):198-209
pubmed: 31913147
J Clin Epidemiol. 2019 Aug;112:53-58
pubmed: 31009658
J Cachexia Sarcopenia Muscle. 2019 Aug;10(4):734-747
pubmed: 31016887
Ann Intensive Care. 2020 Jun 6;10(1):73
pubmed: 32506258
Crit Care Clin. 2000 Apr;16(2):337-52, vii
pubmed: 10768085
Clin Immunol. 2020 Jun;215:108427
pubmed: 32325252
Crit Care. 2015 Aug 05;19:274
pubmed: 26242743
Yale J Biol Med. 1993 Sep-Oct;66(5):501-10
pubmed: 7825351
Crit Care Med. 2008 Aug;36(8):2238-43
pubmed: 18596631
Intensive Care Med. 1996 Jul;22(7):707-10
pubmed: 8844239
J Intensive Care Med. 2020 Dec;35(12):1564-1575
pubmed: 31455133
Curr Opin Crit Care. 2012 Oct;18(5):533-9
pubmed: 22951930
JAMA. 2001 Oct 10;286(14):1754-8
pubmed: 11594901